Table I.
Recipient demographics and clinical characteristics stratified by cohort
| Category | Pre-COVID-19 (n = 274) | COVID-19 (n = 70) | P value |
|---|---|---|---|
| Age, y, n (SD) | 53.2 (17.1) | 56.2 (10.9) | .17 |
| Sex, female, n (%) | 105 (38.3%) | 20 (29.0%) | .14 |
| Race, n (%) | .25 | ||
| Non-Hispanic white | 251 (91.6%) | 63 (91.3%) | |
| African American | 13 (4.7%) | 6 (8.7%) | |
| MELD score—match, mean (SD) | 22.6 (7.6) | 18.9 (7.51) | <.01 |
| Meld score—lab, mean (SD) | 19.8 (8.7) | 17.4 (7.8) | .04 |
| Etiology of liver disease, n (%) | <.01 | ||
| NASH | 98 (35.7%) | 27 (38.0%) | |
| Alcoholic liver disease | 85 (30.9%) | 22 (31.0%) | |
| Viral liver disease | 38 (13.8%) | 3 (4.23%) | |
| Biliary disease | 21 (7.6%) | 1 (1.4%) | |
| Malignancy | 3 (1.1%) | 7 (9.9%) | |
| Fulminant | 3 (1.1%) | 2 (2.8%) | |
| Other | 27 (9.8%) | 9 (12.7%) | |
| Admitted at time of OLT, yes, n (%) | 54 (19.6%) | 11 (15.5%) | .43 |
| ICU at time of OLT, yes, n (%) | 20 (17.4%) | 6 (8.5%) | .09 |
| Hospitalized in previous 90 days, yes, n (%) | 92 (33.5%) | 17 (23.9%) | .12 |
| Intubated at time of OLT, yes, n (%) | 6 (2.2%) | 4 (5.6%) | .12 |
| Current smoker, yes, n (%) | 3 (3.1%) | 1 (1.5%) | .49 |
COVID-19, coronavirus disease 2019; MELD, model of end-stage liver disease; NASH, non-alcoholic steatohepatitis; ICU, intensive care unit; OLT, orthotopic liver transplantation; SD, standard deviation.